Literature DB >> 6837838

Appraisals of compounds of diverse chemical classes for capacities to cure infections with sporozoites of Plasmodium cynomolgi.

L H Schmidt.   

Abstract

Compounds (265) of widely diverse structures were appraised for radical curative activity in rhesus monkeys infected with sporozoites of the B strain of Plasmodium cynomolgi, using an evaluation system that provided a preliminary assessment with from 0.1-1.0 g of compound and tests against one to five active infections. None of 32 compounds in a miscellaneous structure category, none of seven agents of antibiotic origin, none of 12 1,5-naphthyridines, and none of seven 7-aminoquinolines exhibited curative activity at the largest test doses. There was a suggestion that one of 12 newly synthesized pyrocatechols was curative. Two of 20 6-aminoquinolines effected cure at or near maximum tolerated doses. In contrast, 90 of 174 newly synthesized 8-aminoquinolines effected cure; 18 of the 90 being as active as primaquine, eight twice as active, and six four times as active. There were major disagreements between the above results and those recorded by others in mice inoculated with sporozoites of P. berghei yoelii or P. yoelii nigeriensis. These discrepancies were of serious dimensions in evaluations of the 8-aminoquinolines. This, plus previous near flawless performances of P. cynomolgi in identifying agents that would cure naturally acquired P. vivax infections, led to the suggestion that the abbreviated simian model employed in these studies be used hereafter in primary screening of new agents for radical curative activity.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6837838     DOI: 10.4269/ajtmh.1983.32.231

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  14 in total

1.  Use of a rhesus Plasmodium cynomolgi model to screen for anti-hypnozoite activity of pharmaceutical substances.

Authors:  Gregory A Deye; Montip Gettayacamin; Pranee Hansukjariya; Rawiwan Im-erbsin; Jetsumon Sattabongkot; Yarrow Rothstein; Louis Macareo; Susan Fracisco; Kent Bennett; Alan J Magill; Colin Ohrt
Journal:  Am J Trop Med Hyg       Date:  2012-06       Impact factor: 2.345

Review 2.  8-Aminoquinoline Therapy for Latent Malaria.

Authors:  J Kevin Baird
Journal:  Clin Microbiol Rev       Date:  2019-07-31       Impact factor: 26.132

3.  Lead optimization of imidazopyrazines: a new class of antimalarial with activity on Plasmodium liver stages.

Authors:  Bin Zou; Advait Nagle; Arnab K Chatterjee; Seh Yong Leong; Liying Jocelyn Tan; Wei Lin Sandra Sim; Pranab Mishra; Prasuna Guntapalli; David C Tully; Suresh B Lakshminarayana; Chek Shik Lim; Yong Cheng Tan; Siti Nurdiana Abas; Christophe Bodenreider; Kelli L Kuhen; Kerstin Gagaring; Rachel Borboa; Jonathan Chang; Chun Li; Thomas Hollenbeck; Tove Tuntland; Anne-Marie Zeeman; Clemens H M Kocken; Case McNamara; Nobutaka Kato; Elizabeth A Winzeler; Bryan K S Yeung; Thierry T Diagana; Paul W Smith; Jason Roland
Journal:  ACS Med Chem Lett       Date:  2014-07-06       Impact factor: 4.345

4.  Activities of the tetrahydrofuran derivative, BA-41,799, against Plasmodium cynomolgi infections in rhesus monkeys.

Authors:  L H Schmidt
Journal:  Antimicrob Agents Chemother       Date:  1985-02       Impact factor: 5.191

5.  Relationships between chemical structures of 8-aminoquinolines and their capacities for radical cure of infections with Plasmodium cynomolgi in rhesus monkeys.

Authors:  L H Schmidt
Journal:  Antimicrob Agents Chemother       Date:  1983-11       Impact factor: 5.191

6.  Activities of respository preparations of cycloguanil pamoate and 4,4'-diacetyldiaminodiphenylsulfone, alone and in combination, against infections with Plasmodium cynomolgi in rhesus monkeys.

Authors:  L H Schmidt; R N Rossan
Journal:  Antimicrob Agents Chemother       Date:  1984-11       Impact factor: 5.191

7.  Screening procedure using chicks infected with the sporozoites of Plasmodium gallinaceum in an antimalarial drug development programme.

Authors:  K E Kinnamon; D E Davidson; D S Rane
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

8.  Antimalarial activities and subacute toxicity of RC-12, a 4-amino-substituted pyrocatechol.

Authors:  L H Schmidt; R N Rossan; R Fradkin; R Sullivan; W Schulemann; L Kratz
Journal:  Antimicrob Agents Chemother       Date:  1985-11       Impact factor: 5.191

9.  Enhancement of the curative activity of primaquine by concomitant administration of mirincamycin.

Authors:  L H Schmidt
Journal:  Antimicrob Agents Chemother       Date:  1985-02       Impact factor: 5.191

10.  Isolation of GFP-expressing Malarial Hypnozoites by Flow Cytometry Cell Sorting.

Authors:  Annemarie Voorberg-van der Wel; Sam O Hofman; Clemens H M Kocken
Journal:  Bio Protoc       Date:  2021-05-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.